by Igor Hajdukovic | Oct 21, 2026 | Uncategorized
Financing can spread the cost of acquiring aesthetic equipment and help a clinic preserve working capital. For clinics considering medical aesthetic device financing in Canada, typical terms range from 24 to 84 months, while the available structure, payment and...
by Igor Hajdukovic | Oct 20, 2026 | Uncategorized
What if your clinic’s next revenue gain comes from making better use of existing capacity rather than adding another service? Understanding how to increase aesthetic clinic revenue in 2026 starts with identifying which services, appointment slots and follow-up...
by Igor Hajdukovic | Oct 19, 2026 | Uncategorized
What does “precision” mean when plasma technologies differ in how they deliver energy and interact with skin? For clinicians, precision plasma technology for dermatology is not a single treatment category, and evidence for one device or indication cannot automatically...
by Igor Hajdukovic | Oct 18, 2026 | Uncategorized
What if two plasma devices list similar technical specifications but operate differently and serve distinct clinical purposes? That’s why professional medical plasma device specs need to be read in context, not compared as a set of numbers alone.For Canadian...
by Igor Hajdukovic | Oct 17, 2026 | Uncategorized
The most advanced device isn’t automatically the right choice for a patient with dry eye. Effective dry eye disease management technology should be selected according to the clinical presentation and likely underlying mechanisms, not novelty alone. Meibomian gland...
by Igor Hajdukovic | Oct 16, 2026 | Uncategorized
What does “plasma” mean in ophthalmology: a blood-derived therapy, an ionized gas, or a device-based treatment? The distinction matters. Plasma technology for ophthalmology covers different mechanisms, and the label alone does not explain how a technology works or...
